<DOC>
	<DOCNO>NCT01258569</DOCNO>
	<brief_summary>Entereg ( Alvimopan ) peripherally act mu-opioid receptor antagonist show increase postoperative bowel function patient open bowel resection surgery . It proven safe effective short-term in-house treatment . At present several Drug Use Utilization Evaluation study report result involve use alvimopan ( ENTEREG ) laparoscopic bowel resection patient . However , study first randomize , prospective , double-blind , placebo-controlled trial look population . We propose Entereg decrease length stay one day laparoscopic colon resection patient . We wish perform voluntary , double-blinded , placebo control study . We plan enrollment population 250 patient . Twelve milligrams Entereg administer 30 minute 5 hour pre-op follow 12 mg BID , 7 day 15 total dos . The primary endpoint study length stay . The time GI-2 recovery ( toleration solid food first bowel movement ) time GI-3 recovery ( toleration solid food , flatus bowel movement ) secondary endpoint . Estimated Enrollment = 250 , Study Start Date : November 2010 , Estimated Study Completion Date : May 2012 , Estimated Primary Completion Date : Nov 2011 .</brief_summary>
	<brief_title>Entereg Laparoscopic Colon Resection Study</brief_title>
	<detailed_description />
	<mesh_term>Alvimopan</mesh_term>
	<criteria>Subject schedule undergo laparoscopic ( straight hand assist ) elective colon resection primary anastamosis Subject &gt; 18 year age Subjects either male female Negative pregnancy test ( patient premenopausal female ) Medically stable determine treat surgeon i.e. , subject American Society Anesthesiologists Physical Status Score I III . Subject understand study procedure , agree participate study per study protocol , voluntarily provide informed consent Patients receive IV Opioid therapy post surgery pain management . Subject pregnant lactating Subject currently use opioids take 3 dos opioids ( oral parenteral ) week prior surgery . Subject complete bowel obstruction Subject able understand inform consent document unable give inform consent Patients receive thoracic epidural pain management post surgery . Subject medical instability condition screening/enrollment , opinion investigator , might confound result study pose additional risk subject administration study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>laparoscopic</keyword>
	<keyword>colon</keyword>
	<keyword>resection</keyword>
	<keyword>Entereg</keyword>
</DOC>